Skip navigation

Login / Register


0113 202 9799

Lipid Management

With cardiovascular disease (CVD) responsible for 1 in 4 deaths in the UK, lipid management for secondary prevention of atherosclerotic cardiovascular disease (ASCVD) is a clinical priority for patients and the NHS. Interface can proactively support primary care with their lipid management.

Patients requiring lipid optimisation for secondary prevention of Atherosclerotic Cardiovascular Disease (ASCVD) can be identified and reviewed, preventing further cardiovascular events including heart attacks and strokes.

The service can support practices to optimise their clinical management in line with national and local guidelines, and help achieve their QOF indicators.

Lipid Management Therapy Reviews

Get in touch to discuss Lipid support further or apply here directly


    Need some help? Get in touch

    Lipid Management


      Our pharmacist-led service can: 

      • Stratify patients with a diagnosis of ASCVD and report on their current management,  identifying patients who may benefit from review and treatment optimisation.
      • Provide clinical capacity to deliver patient-facing or virtual clinics.
      • Provide mentorship opportunities for practice teams to support sustained quality improvement in lipid management. 
      • Support the achievement of CHOL001 and CHOL002 QOF indicators.

      QOF Disease Prevalence Coding Support

      Our Clinical Pharmacists are now able to offer coding support across a number of QOF domains

      Find out more